Bank of America’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.98M | Buy |
661,285
+136,900
| +26% | +$1.03M | ﹤0.01% | 3319 |
|
|
2025
Q1 | $3.97M | Buy |
524,385
+369,115
| +238% | +$2.79M | ﹤0.01% | 3412 |
|
|
2024
Q4 | $1.89M | Sell |
155,270
-254,523
| -62% | -$3.1M | ﹤0.01% | 3788 |
|
|
2024
Q3 | $6.86M | Sell |
409,793
-2,952
| -0.7% | -$49.4K | ﹤0.01% | 2933 |
|
|
2024
Q2 | $7.2M | Buy |
412,745
+281,396
| +214% | +$4.91M | ﹤0.01% | 2813 |
|
|
2024
Q1 | $2.24M | Sell |
131,349
-4,063
| -3% | -$69.2K | ﹤0.01% | 3666 |
|
|
2023
Q4 | $1.38M | Buy |
135,412
+32,095
| +31% | +$327K | ﹤0.01% | 3907 |
|
|
2023
Q3 | $935K | Buy |
103,317
+83,529
| +422% | +$756K | ﹤0.01% | 4063 |
|
|
2023
Q2 | $213K | Sell |
19,788
-66,413
| -77% | -$715K | ﹤0.01% | 4965 |
|
|
2023
Q1 | $882K | Buy |
86,201
+16,372
| +23% | +$167K | ﹤0.01% | 4255 |
|
|
2022
Q4 | $737K | Buy |
69,829
+6,930
| +11% | +$73.1K | ﹤0.01% | 4425 |
|
|
2022
Q3 | $806K | Buy |
62,899
+34,227
| +119% | +$439K | ﹤0.01% | 4337 |
|
|
2022
Q2 | $367K | Sell |
28,672
-16,761
| -37% | -$215K | ﹤0.01% | 4927 |
|
|
2022
Q1 | $475K | Buy |
45,433
+16,384
| +56% | +$171K | ﹤0.01% | 5162 |
|
|
2021
Q4 | $448K | Buy |
29,049
+19,785
| +214% | +$305K | ﹤0.01% | 5200 |
|
|
2021
Q3 | $209K | Sell |
9,264
-5,372
| -37% | -$121K | ﹤0.01% | 5442 |
|
|
2021
Q2 | $376K | Sell |
14,636
-8,699
| -37% | -$223K | ﹤0.01% | 4910 |
|
|
2021
Q1 | $972K | Buy |
+23,335
| New | +$972K | ﹤0.01% | 4274 |
|